Thursday, October 30 |
||
Luncheon Symposium 1![]() |
Thursday, October 30,
12:00-12:30 Room 1 CRYSTAL 1 (3F) |
|
---|---|---|
Chair | TBD (TBD) | |
12:00-12:30 |
Key Findings of SPARK & FLAME Study
Wisia Wedzicha (Imperial College London, UK)
|
|
Luncheon Symposium 2![]() |
Thursday, October 30,
12:00-12:30 Room 2 CRYSTAL 2 (3F) |
|
Chair | TBD (TBD) | |
12:00-12:30 |
Progress to PerFection: Navigating the Path from Diagnosis to Advanced Treatment of PPF
Martin Kolb (McMaster University, Canada)
|
|
Luncheon Symposium 3![]() |
Thursday, October 30,
12:00-12:30 Room 3 CRYSTAL 3 (3F) |
|
Chair | TBD (TBD) | |
12:00-12:30 |
The LASER Effect : Lazertinib's Rise as a New SoC in EGFR m+ NSCLC 1st Line Treatment
Mi-Hyun Kim (Pusan National University, Korea)
|
|
Luncheon Symposium 4![]() |
Thursday, October 30,
12:00-12:30 Room 4 EMERALD (3F) |
|
Chair | TBD (TBD) | |
12:00-12:30 |
Making Sense of Severe Asthma Today : Insights from Guidelines and New Evidences
Arnaud Bourdin (University of Montpellier, France)
|
|
Friday, October 31 |
||
Luncheon Symposium 5![]() |
Friday, October 31,
11:50-12:20 Room 1 CRYSTAL 1 (3F) |
|
Chair | TBD (TBD) | |
11:50-12:20 |
Disease Stability in COPD: An Important Treatment Goal
Dave Singh (University of Manchester, UK)
|
|
Luncheon Symposium 6![]() |
Friday, October 31,
11:50-12:20 Room 2 CRYSTAL 2 (3F) |
|
Chair | TBD (TBD) | |
11:50-12:20 |
Innovative Therapeutic Frontiers: The Current and Future Pharmacological Landscape for Idiopathic Pulmonary Fibrosis (IPF)
Kevin Brown (National Jewish Center, USA)
|
|
Luncheon Symposium 7![]() |
Friday, October 31,
11:50-12:20 Room 3 CRYSTAL 3 (3F) |
|
Chair | TBD (TBD) | |
11:50-12:20 |
When Standard isn’t Enough: A New treatment pathway with FLAURA2
Seong Hoon Yoon (Pusan National University, Korea)
|
|
Luncheon Symposium 8![]() |
Friday, October 31,
11:50-12:20 Room 4 EMERALD (3F) |
|
Chair | TBD (TBD) | |
11:50-12:20 |
TBD
Hyun Lee (Hanyang University, Korea)
|